Skip to content

Study on Sleep Characteristics, Inflammatory Mechanisms and Predictive Models of Depression Comorbid with Metabolic Syndrome

Study on Sleep Characteristics, Inflammatory Mechanisms and Predictive Models of Depression Comorbid with Metabolic Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126864
Enrollment
Unknown
Registered
2026-06-17
Start date
2025-08-30
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Depression-Only Group (without metabolic syndrome):None
Healthy Control Group:None
Depression with Comorbid Metabolic Syndrome Group:None

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Healthy Control Group: (1)Chinese Han ethnicity, aged 18-65 years, male or female, with at least primary school education; (2)No mental disorder meeting ICD-10 or DSM-5 diagnostic criteria; (3)Does not meet the diagnostic criteria for metabolic syndrome (according to IDF criteria); (4)Hamilton Depression Rating Scale (HAMD-17) score = 18; (5)Voluntary participation with signed written informed consent. 3. Depression with Comorbid Metabolic Syndrome Group: (1)Meets ICD-10 or DSM-5 diagnostic criteria for depressive disorder, and does not meet criteria for any other Axis I diagnosis in DSM-IV; (2)Chinese Han ethnicity, aged 18-65 years, male or female, with at least primary school education; (3)Meets the diagnostic criteria for metabolic syndrome (according to IDF criteria: central obesity plus any two metabolic abnormalities); (4)Hamilton Depression Rating Scale (HAMD-17) score >= 18; (5)Voluntary participation with signed written informed consent.

Exclusion criteria

Exclusion criteria: 1.Other psychiatric disorders such as bipolar disorder/schizophrenia/substance dependence; 2.Severe physical diseases (e.g., cancer, liver failure) not including metabolic syndrome; 3.Presence of primary sleep apnea (AHI > 15); 4.History of severe traumatic brain injury or central nervous system diseases; 5.Pregnant or lactating women; 6.Received ECT/MECT treatment within the past 6 months; 7.Refusal to sign a written informed consent form.

Design outcomes

Primary

MeasureTime frame
PSG parameters;Clinical Scale;

Secondary

MeasureTime frame
Inflammatory markers;General data;

Countries

China

Contacts

Public ContactWang Qi, Luan Peipei

Wuxi Mental Health Center

wangqi200101@163.com+86 510 83219310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026